Tiffany is a Vice President at H.I.G. BioHealth Partners, where she focuses on investment opportunities in the life sciences industry, including biopharmaceuticals, medical devices and diagnostics. Prior to joining H.I.G., Tiffany was at ZS Associates, where she focused on strategy and transformation initiatives for pharmaceutical and medical device companies regarding commercial launch strategy, mergers and acquisitions, and change management. Previously, Tiffany began her career at BMO Capital Markets, where she advised healthcare clients on M&A transactions, capital raises and other strategic initiatives. Tiffany earned her undergraduate degree in Economics and Mathematics, cum laude, from Smith College.
